Global Medical REIT Inc. financial data

Symbol
GMRE, GMRE-PA, GMRE-PB on NYSE
Location
Bethesda, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 146% % 23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13,407,358 shares -80%
Common Stock, Shares, Outstanding 13,407,000 shares -80%
Entity Public Float $561,000,000 USD -0.53%
Common Stock, Value, Issued $13,000 USD -81%
Weighted Average Number of Shares Outstanding, Basic 13,393,000 shares 1.9%
Weighted Average Number of Shares Outstanding, Diluted 13,393,000 shares 1.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $144,973,000 USD 6.1%
General and Administrative Expense $22,212,000 USD 26%
Earnings Per Share, Basic 0 USD/shares -678%
Earnings Per Share, Diluted 0 USD/shares -678%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,123,000 USD 24%
Operating Lease, Right-of-Use Asset $13,222,000 USD 80%
Goodwill $5,903,000 USD 0%
Assets $1,273,238,000 USD 2.5%
Employee-related Liabilities, Current $3,200,000 USD
Liabilities $767,410,000 USD 13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $7,467,000 USD -50%
Retained Earnings (Accumulated Deficit) $332,566,000 USD -18%
Stockholders' Equity Attributable to Parent $485,289,000 USD -11%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $505,828,000 USD -10%
Liabilities and Equity $1,273,238,000 USD 2.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,272,000 USD -14%
Net Cash Provided by (Used in) Financing Activities $13,598,000 USD
Net Cash Provided by (Used in) Investing Activities $27,224,000 USD -902%
Common Stock, Shares Authorized 100,000,000 shares -80%
Common Stock, Shares, Issued 13,407,000 shares -80%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,354,000 USD -225%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9,840,000 USD 26%
Interest Paid, Excluding Capitalized Interest, Operating Activities $6,568,000 USD 2.5%
Operating Lease, Liability $13,505,000 USD 79%
Depreciation $43,021,000 USD 6.4%
Lessee, Operating Lease, Liability, to be Paid $32,131,000 USD 149%
Property, Plant and Equipment, Gross $1,508,711,000 USD 5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,150,000 USD 52%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,134,000 USD 53%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,626,000 USD 248%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,174,000 USD 52%
Preferred Stock, Shares Issued 3,105,000 shares 0%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,193,000 USD 50%
Operating Lease, Payments $270,000 USD 57%
Additional Paid in Capital $735,416,000 USD 0.24%
Preferred Stock, Shares Outstanding 3,105,000 shares 0%
Interest Expense $29,512,000 USD 2.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%